XML 15 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
(Unaudited ) Consolidated Statements of Operations (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Net Sales $ 2,949,605 $ 3,115,471 $ 9,154,674 $ 13,410,527
Cost of Goods Sold 2,675,132 2,536,463 8,025,657 10,325,668
Gross Profit 274,473 579,008 1,129,017 3,084,859
Operating Expenses:        
Selling expenses 654,005 557,235 1,943,522 1,816,612
General and administrative expenses 568,944 565,284 1,773,073 1,773,212
Non-cash compensation expenses 276,969 32,602 1,051,857 97,805
Research and development expenses 92,276 91,202 350,515 470,502
Total Operating Expenses 1,592,194 1,246,323 5,118,967 4,158,131
Loss from Operations (1,317,721) (667,315) (3,989,950) (1,073,272)
Other Income (Expense)        
Interest and other income 9,313 12,455 11,713 111,294
Interest (expense) (14,381) (7,376) (39,038) (133,264)
Gain on currency transactions 115,011 12,478 78,037 76,077
(Loss) on sale of fixed assets     (2,135)  
Total Other Income 109,943 17,557 48,577 54,107
Loss Before Income Taxes (1,207,778) (649,758) (3,941,373) (1,019,165)
Income Tax Benefit (303,784) (221,886) (1,045,307) (361,386)
Net Loss (903,994) (427,872) (2,896,066) (657,779)
Less Net Loss Attributable To Non-Controlled Interests in Subsidiaries (38)   (14,197)  
Net Loss Attributable To LiqTech $ (903,956) $ (427,872) $ (2,881,869) $ (657,779)
Basic Loss Per Share (in Dollars per share) $ (0.04) $ (0.02) $ (0.12) $ (0.03)
Weighted Average Common Shares Outstanding (in Shares) 24,511,500 24,111,500 24,329,082 23,488,208
Diluted Loss Per Share (in Dollars per share) $ (0.04) $ (0.02) $ (0.12) $ (0.03)
Weighted Average Common Shares Outstanding Assuming Dilution (in Shares) 24,511,500 24,111,500 24,329,082 23,488,208